These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 12800468)

  • 1. 52nd Annual Scientific Session of the American College of Cardiology, Chicago, March 30-April 2, 2003.
    Owen OG
    Int J Clin Pract; 2003 May; 57(4):338-9. PubMed ID: 12800468
    [No Abstract]   [Full Text] [Related]  

  • 2. American College of Cardiology--52nd annual scientific session: 29 March-2 April 2003, Chicago, IL, USA.
    Susman E
    IDrugs; 2003 Jun; 6(6):531-5. PubMed ID: 12861978
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of two lipid lowering therapies on immune responses in hyperlipidemic subjects.
    Moreira FT; Ramos SC; Monteiro AM; Helfenstein T; Gidlund M; Damasceno NR; Neto AM; Izar MC; Fonseca FA
    Life Sci; 2014 Mar; 98(2):83-7. PubMed ID: 24447629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New advances in lipid-modifying therapies for reducing cardiovascular risk.
    Bruckert E
    Cardiology; 2002; 97(2):59-66. PubMed ID: 11978950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid altering-efficacy of ezetimibe co-administered with simvastatin compared with rosuvastatin: a meta-analysis of pooled data from 14 clinical trials.
    Catapano A; Brady WE; King TR; Palmisano J
    Curr Med Res Opin; 2005 Jul; 21(7):1123-30. PubMed ID: 16004682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abstracts from the XIV International Symposium on Drugs Affecting Lipid Metabolism. September 9-12, 2001, New York, USA.
    Int J Clin Pract Suppl; 2002 Feb; (124):1-15. PubMed ID: 11939162
    [No Abstract]   [Full Text] [Related]  

  • 7. Statins: how far have we come? A review of rosuvastatin.
    Olsson A
    Int J Clin Pract Suppl; 2003 Oct; (137):15-25. PubMed ID: 14649698
    [No Abstract]   [Full Text] [Related]  

  • 8. Rosuvastatin--'the super statin'.
    Jan M
    J Ayub Med Coll Abbottabad; 2001; 13(2):1-2. PubMed ID: 11732211
    [No Abstract]   [Full Text] [Related]  

  • 9. Two more drugs for dyslipidemia.
    Roberts WC
    Am J Cardiol; 2004 Mar; 93(6):809-11. PubMed ID: 15019903
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical experience with rosuvastatin in the management of hyperlipidemia and the reduction of cardiovascular risk.
    Nicholls SJ; Uno K; Kataoka Y
    Expert Rev Cardiovasc Ther; 2011 Nov; 9(11):1383-90. PubMed ID: 22059787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abstracts of the 52nd Annual Scientific Session of the American College of Cardiology. Chicago, Illinois, USA. March 30-April 2, 2003.
    J Am Coll Cardiol; 2003 Mar; 41(6 Suppl A):1A-685A. PubMed ID: 12643267
    [No Abstract]   [Full Text] [Related]  

  • 12. The statin wars.
    McKillop T
    Lancet; 2003 Nov; 362(9394):1498. PubMed ID: 14602449
    [No Abstract]   [Full Text] [Related]  

  • 13. New analysis supports expanded use of statins in women.
    Harv Womens Health Watch; 2010 Apr; 17(8):6. PubMed ID: 20506603
    [No Abstract]   [Full Text] [Related]  

  • 14. Lipid-altering efficacy of the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients.
    Catapano AL; Davidson MH; Ballantyne CM; Brady WE; Gazzara RA; Tomassini JE; Tershakovec AM
    Curr Med Res Opin; 2006 Oct; 22(10):2041-53. PubMed ID: 17022864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Best of the American College of Cardiology 52nd annual session. March 30-April 2, 2003, Chicago, Illinois, USA.
    Rev Cardiovasc Med; 2003; 4(3):150-79. PubMed ID: 14531378
    [No Abstract]   [Full Text] [Related]  

  • 16. The efficacy and safety of ezetimibe/simvastatin combination compared with intensified lipid-lowering treatment strategies in diabetic subjects with and without metabolic syndrome.
    Jimenez JG; Rosen JB; Pirags V; Massaad R; Hanson ME; Brudi P; Triscari J
    Diabetes Obes Metab; 2013 Jun; 15(6):513-22. PubMed ID: 23279632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [JUPITER study, more reason to give statins as preventive measure - commentary].
    Narkiewicz K
    Kardiol Pol; 2009 Mar; 67(3):346-7. PubMed ID: 19469067
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy and safety of ezetimibe added to atorvastatin versus atorvastatin uptitration or switching to rosuvastatin in patients with primary hypercholesterolemia.
    Bays HE; Averna M; Majul C; Muller-Wieland D; De Pellegrin A; Giezek H; Lee R; Lowe RS; Brudi P; Triscari J; Farnier M
    Am J Cardiol; 2013 Dec; 112(12):1885-95. PubMed ID: 24063830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological treatment of a Sardinian patient affected by Autosomal Recessive Hypercholesterolemia (ARH).
    Muntoni S; Pisciotta L; Muntoni S; Bertolini S
    J Clin Lipidol; 2015; 9(1):103-6. PubMed ID: 25670367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effect of simvastatin versus simvastatin/ezetimibe versus rosuvastatin on markers of inflammation and oxidative stress in subjects with hypercholesterolemia.
    Moutzouri E; Liberopoulos EN; Tellis CC; Milionis HJ; Tselepis AD; Elisaf MS
    Atherosclerosis; 2013 Nov; 231(1):8-14. PubMed ID: 24125402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.